NASDAQ:ANIX Anixa Biosciences - ANIX News Today Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Anixa Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. $4.46 +0.05 (+1.13%) (As of 01/27/2023 12:00 AM ET) Add Compare Share Share Today's Range$4.31▼$4.6250-Day Range$3.78▼$5.0452-Week Range$2.30▼$6.25Volume44,601 shsAverage Volume38,099 shsMarket Capitalization$137.90 millionP/E RatioN/ADividend YieldN/APrice Target$8.00 ProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial Media Get Anixa Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for ANIX and its competitors with MarketBeat's FREE daily newsletter. Email Address ANIX Media Mentions By Week ANIX Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ANIX News Sentiment▼0.950.71▲Average Medical News Sentiment ANIX News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ANIX Articles This Week▼20▲ANIX Articles Average Week All Sources Trusted Sources MarketBeat.com Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineAre Investors Undervaluing Anixa Biosciences, Inc. (NASDAQ:ANIX) By 38%?finance.yahoo.com - January 24 at 10:21 AMAnixa Biosciences, Inc. (NASDAQ:ANIX): Is Breakeven Near?finance.yahoo.com - December 28 at 8:46 AMAnixa Biosciences to Present at Biotech Showcase 2023finance.yahoo.com - December 19 at 10:06 AMAnixa Biosciences Increuters.com - December 17 at 11:14 PMAnixa Biosciences Announces Maximum Tolerated Dose Reached in Trial of Preventative Breast Cancer Vaccinefinance.yahoo.com - December 8 at 9:33 AMAnixa Biosciences Announces Presentation on Breast Cancer Vaccine Trial at the 2022 San Antonio Breast Cancer Symposiumfinance.yahoo.com - November 8 at 11:50 AMDr. Jose Conejo-Garcia, Invited to Present Keynote Address at Duke Cancer Institute, will Discuss Anixa Biosciences' Ovarian Cancer CAR-T Therapyfinance.yahoo.com - October 31 at 10:35 AMWhat Makes ANIXA BIOSCIENCES INC (ANIX) a Good Fit for "Trend Investing"finance.yahoo.com - October 28 at 1:13 PMAnixa Biosciences Announces Commencement of Phase 1b Trial of its Breast Cancer Vaccine at Cleveland Clinicfinance.yahoo.com - October 26 at 9:23 AMANIX Anixa Biosciences, Inc.seekingalpha.com - October 11 at 1:42 PMAnixa Biosciences Announces Presentation on Ovarian Cancer CAR-T Therapy Trial at the Society for Immunotherapy of Cancer (SITC) Annual Meetingfinance.yahoo.com - October 10 at 12:39 PMAnixa Biosciences' Ovarian Cancer CAR-T Therapy to be Presented at the Rivkin Center & American Association of Cancer Research (AACR) 14th Biennial Ovarian Cancer Research Symposiumfinance.yahoo.com - September 12 at 10:49 AMAnixa Initiates Patient Dosing in Initial-Stage Ovarian Cancer Studymsn.com - August 15 at 10:51 AMAnixa Biosciences Announces Treatment of First Patient in its Ovarian Cancer CAR-T Clinical Trialfinance.yahoo.com - August 15 at 10:51 AMAnixa Publishes Scientific Paper On Preventative Ovarian Cancer Technologynasdaq.com - June 21 at 10:55 AMAnixa Biosciences Announces Publication of Peer-Reviewed Journal Article in Clinical and Experimental Vaccine Research Highlighting Ovarian Cancer Vaccine Technologyfinance.yahoo.com - June 21 at 9:32 AMAnixa Biosciences, Inc. (ANIX)finance.yahoo.com - June 16 at 12:55 AMAnixa Biosciences (NASDAQ:ANIX) Is In A Strong Position To Grow Its Businessfinance.yahoo.com - May 18 at 7:34 AMAnixa: Making Sense Of A Bullish Move Up In Bearish Biotech Timesseekingalpha.com - May 11 at 2:01 PMHas Anixa Biosciences (ANIX) Outpaced Other Medical Stocks This Year?finance.yahoo.com - May 2 at 12:03 PMAnixa Biosciences Announces Presentation on Breast Cancer Vaccine Trial at the American Society of Clinical Oncology (ASCO) Annual Meetingfinance.yahoo.com - April 28 at 8:42 AMAnixa Biosciences' Ovarian Cancer CAR-T Therapy to be Discussed at The 4th International Workshop on CAR-T 2022finance.yahoo.com - April 6 at 11:55 AMAnixa Biosciences initiates phase 1 trial of its ovarian cancer CAR-T therapyseekingalpha.com - March 30 at 5:47 PMAnixa Biosciences Announces the Initiation of its Ovarian Cancer CAR-T Phase 1 Trial at Moffitt Cancer Centerfinance.yahoo.com - March 30 at 5:47 PMAnixa Biosciences, Inc.(ANIX)fool.com - March 18 at 7:35 AMAnixa Biosciences to Participate in the 2022 Virtual Growth Conference Hosted by M-Vest, a Division of Maxim Group LLCfinance.yahoo.com - March 17 at 4:16 PMPre-market Movers: HUSA, BBBY, NINE, IMPP, MXC…nasdaq.com - March 7 at 10:36 AMAnixa Biosciences Announces Japanese Patent on Ovarian Cancer Vaccinefinance.yahoo.com - January 25 at 12:40 PMAnixa says new protease inhibitor trumps main agent in Pfizer’s COVID-19 pillseekingalpha.com - January 24 at 9:53 AMAnixa Biosciences and MolGenie Announce Early Potency Analysis of SARS-CoV-2 Protease Inhibitorfinance.yahoo.com - January 24 at 8:54 AMAnixa Biosciences Inc Shares Close in on 52-Week Low - Market Movernasdaq.com - January 6 at 8:08 AMAnixa Biosciences to Participate in Upcoming January Investor Conferences: LifeSci Partners Annual Corporate Access Event and H.C. Wainwright BioConnect Conferencefinance.yahoo.com - December 16 at 9:32 AMAnixa Biosciences, MolGenie Report Their COVID-19 Compounds Expected To Be Effective Against Omicron Variantbenzinga.com - December 7 at 2:31 PMAnixa : COVID-19 Compounds Expected To Be Effective Against Omicron And Delta Variantsmarkets.businessinsider.com - December 7 at 10:08 AMAnixa Biosciences and MolGenie Announce that their COVID-19 Compounds are Expected to be Effective Against the Omicron Variantfinance.yahoo.com - December 7 at 9:30 AMThe First Human Trial of a Prevenative Breast Cancer Vaccinenasdaq.com - October 28 at 6:55 PMTrial launched for first-ever vaccine to prevent breast cancermsn.com - October 27 at 3:15 PMCleveland Clinic begins new clinical trial for vaccine aimed at stopping aggressive breast cancermsn.com - October 26 at 9:47 AMAnixa Biosciences Announces Patient Dosing of its Investigational Vaccine Candidate in a First-of-its-Kind Preventative Breast Cancer Vaccine Studyfinance.yahoo.com - October 26 at 9:47 AMAnixa Biosciences Announces First Chinese Patent on its CAR-T Cancer Therapy Technologyfinance.yahoo.com - October 6 at 1:02 PMAnixa Biosciences Announces Notice of Allowance for Additional Patent on its CAR-T Cancer Therapyfinance.yahoo.com - October 1 at 11:55 AMAnixa Biosciences' Ovarian Cancer CAR-T Therapy to be Discussed at Upcoming Emerging Immunotherapeutics for Ovarian Cancer Symposiumfinance.yahoo.com - September 14 at 10:25 AMAnixa Biosciences to Present at the H.C. Wainwright 23rd Annual Global Investment Conferencefinance.yahoo.com - September 8 at 8:47 AMAnixa Biosciences Appoints Dr. Pamela Garzone As Chief Development Officerfinance.yahoo.com - September 7 at 12:51 PMAnixa (ANIX) Ovarian Cancer CAR-T Drug to Enter Clinical Studyfinance.yahoo.com - August 31 at 5:00 PMBRIEF-Anixa Biosciences Gets FDA Clearance For Ovarian Cancer Trialmsn.com - August 30 at 3:57 PMAnixa Biosciences Says FDA Clears IND For CAR-T Immunotherapy For Ovarian Cancer - Quick Factsnasdaq.com - August 30 at 3:57 PMAnixa Biosciences Shares Rise 5% After FDA Approves Cancer Therapymarketwatch.com - August 30 at 3:57 PMAnixa Biosciences and Moffitt Cancer Center Announce FDA Clearance to Initiate Clinical Trial of Ovarian Cancer CAR-T Immunotherapyfinance.yahoo.com - August 30 at 3:57 PMAnixa Biosciences' COVID-19 Compounds Show Potential Efficacy Against Delta Variantfinance.yahoo.com - August 25 at 9:39 PM Get Anixa Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for ANIX and its competitors with MarketBeat's FREE daily newsletter. Email Address This page (NASDAQ:ANIX) was last updated on 1/28/2023 by MarketBeat.com Staff Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.